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Abstract
The tumor suppressor gene p27
Kip1 plays a fundamental role in human cancer progression. Its expression and/or functions
are altered in almost all the different tumor histotype analyzed so far. Recently, it has been demonstrated that the tumor
suppression function of p27 resides not only in the ability to inhibit Cyclins/CDKs complexes through its N-terminal domain
but also in the capacity to modulate cell motility through its C-terminal portion. Particular interest has been raised by the
last amino-acid, (Threonine 198) in the regulation of both protein stability and cell motility. Here, we describe that the
presence of Threonine in position 198 is of primary importance for the regulation of the protein stability and for the control
of cell motility. However, while the control of cell motility is dependent on the phosphorylation of T198, the stability of the
protein is specifically controlled by the steric hindrance of the last amino acid. The effects of T198 modification on protein
stability are not linked to the capacity of p27 to bind Cyclins/CDKs complexes and/or the F-box protein Skp2. Conversely,
our results support the hypothesis that conformational changes in the disordered structure of the C-terminal portion of p27
are important in its ability to be degraded via a proteasome-dependent mechanism. On the other hand T198
phosphorylation favors p27/stathmin interaction eventually contributing to the regulation of cell motility, supporting the
hypothesis that the presence of T198 is fundamental for the regulation of p27 functions.
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Introduction
The Cyclin Dependent Kinase Inhibitor (CDKI) gene p27
Kip1
(hereafter p27) is frequently altered in human cancer and its low
expression is often associated with a worse prognosis for the patients
[1]. Recent evidences demonstrated that p27 could also be
functionally altered in human tumors [2]. Although the regulation
of p27 could in some settings occurs at transcriptional level [2–3], it
is widely accepted that in human tumors its expression levels are
mainly regulated by post-transcriptional modifications [2]. In
particular it has been shown that p27 expression is regulated by a
proteasome-dependent degradation [4] and that this mechanism
plays a pivotal role in the regulation of p27 expression in several
type of human tumors, as first demonstrated in breast and colon
cancer [5–6]. The proteasome dependent regulationof p27requires
its phosphorylation on the Threonine 187 (T187) by CDK2-
containing complexes. This phosphorylation is necessary for the
binding of p27 to the F-Box protein Skp2 [7–8] and for its
consequent ubiquitination and proteasome-dependent degradation
[reviewed in 9]. More recently it has been shown that the Skp2-
mediated degradation of p27 occurs predominantly during the S
phase [10] in accord with the fact that it requires the activity of the
CDK-containing complexes [11] and a direct phosphorylation on
multiple tyrosine residues [12–13]. The overall scenario depicted
with new available data is that, starting from a state of quiescence in
which the cell has high levels of p27 protein, after growth factor
stimulation, p27 is first phosphorylated on three different tyrosine
residues (Y74, Y88 and/or Y89) by different intracellular tyrosine-
kinases (i.e. c-Src, Bcr-Abl or Lyn, depending on the cellular
context). These phosphorylations allow the CDK2 containing
complexes to phosphorylate the T187 in p27 eventually resulting in
Skp2 binding and ubiquitin-dependent degradation [12–13].
Although this pathway has been widely demonstrated and seems
to play a pivotal role in the control of p27 protein stability in both
normal and cancer cell, at least two Skp2-independent pathways
have been proved to induce p27 degradation during G1: the
KPC1-KPC2 ubiquitin-ligases [14] and the activation of the Wnt-
Cul4A pathway [15]. Both of these pathways could be involved in
the regulation of p27 in human cancer favoring cell proliferation
and tumor progression. However, the modification necessary for
p27 to become a target of either Cul4A or KPC1/2 ubiquitin
ligases are still not identified. Interestingly, the phosphorylation of
p27 on its last residue threonine 198 (T198) by different kinases
[16–17] has been proposed to control not only its stability [18] but
also to modulate its activity in the regulation of cell motility [17].
Most part of the recent literature suggests that in the N-terminal
portion of the protein resides the ability of p27 to bind and inhibit
the activity of several cyclin/CDKs complexes while its C-terminal
domain seems to control protein stability, nuclear localization and
binding to non-CDKs complexes [2].
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are not necessary for the control of cell proliferation but they are
important in the regulation of cell motility [19–20]. Since the last
28 amino-acids of p27 comprise both the T187 and the T198
residues, we asked whether a point mutation in these two key
threonines could recapitulate the effects of the deletion of the last
28 amino-acids. By generating these two mutants we observed that
the T198A mutation determines a drastic reduction of p27 protein
expression as previously reported by others [18]. However, our
data demonstrate that this effect is not due to the absence of
phosphorylation but rather to the steric hindrance of the last
amino-acid, indicating that changes in the conformation of the C-
terminal tail of p27 render the protein more prone to its
proteasomal degradation. Conversely, our experiments of cell
motility indicate that T198 phosphorylation is specifically
necessary for p27 to function as a modulator of cell motility,
favoring its binding to the microtubules destabilizing protein
stathmin.
Materials and Methods
Cell culture, Transfection and Treatments
HT-1080 fibrosarcoma cells (ATCC CCL-121), HEK 293
(ATCC CRL- 1573) and 3T3 p27 null (p27
KO) fibroblasts were
grown in DMEM supplemented with 10% heat-inactivated FBS
(Sigma). U87MG malignant glioma cells (ATCC HTB-14) and
MDAH 2774 ovarian adenocarcinoma cells (ATCC CRL-10303)
were maintained in RPMI-1640 medium supplemented with 10%
heat inactivated FBS. SCC9 squamous cell carcinoma cells (ATCC
CRL-1629) were grown in a 1:1 mixture of DMEM and HAM’S
F12 supplemented as described by the provider. The cells were
transfected with the indicated expression vectors using FuGENE
HD Transfection Reagent (Roche). When indicated, cells were
treated with 10 mg/ml cycloheximide (Sigma) for 3, 6 and 9 hours
and with 50 mM MG132 (Calbiochem) for 6 and 9 hours.
Construction of Expression Vectors
The mutants of p27 were generated by PCR on p27
wt vector
using oligonucleotides carrying the indicated mutations. Amplified
fragments were cloned into pGEM-T Easy Vector (Promega) and
checked by sequencing. The expression vectors utilized were
pEGFP-C (Clontech), pFLAG-CMV 6 (Sigma), pDNR-CMV
(Clontech), pQE-30 (Qiagen) and pTNT (Promega). In the same
way stathmin coding sequence was cloned in the DsRed-
Monomer-C expression vector (Clontech).
Recombinant Adenoviruses
Recombinant adenoviruses for p27 overexpression were pro-
duced with two systems: the Adeno-X Tet ON Expression System 2
(Clontech) and the Adeno-X ViraTrak ZsGreen1 Expression
System 2 (Clontech), according provider’s instructions. To obtain
regulated p27 expression, in the first method target cells were co-
transduced with two viruses: the AdTet-ON (Clontech), that
provides the constitutive expression of the reverse tetracycline-
controlled transactivator (rtTA), and the AdTRE that encodes for
the p27
WT or mutant proteins. Recombinant protein production
was induced using Doxycycline (Sigma) at 1 mg/ml added to cell
culture medium. In the other system the gene of interest and the
gene for the green fluorescence protein are under the control of
distinct CMV promoter, allowing the simultaneous but not fused
expression of the two proteins. The control (AdNeg, Clontech) and
Skp2 siRNA adenoviruses were generated using the BD Knockout
Adenoviral RNAi System 2 (Clontech) following the manufacturer’s
procedures and inserting the appropriate target sequence: human
Skp2: 59-GCCTAAGCTAAATCGAGAGAA-39 (NM_032637,
pos nt 428–449). Adenovirus production, titration and character-
ization were performed as previously described [20].
Expression and Purification of Recombinant Proteins
Production of bacterial recombinant proteins was performed
essentially as previously described [19]. Briefly, p27
WT and p27
mutants cDNAs were cloned in the pQE-30 vector (Qiagen).
Escherichia coli (M15) cells were transformed with the expression
plasmid to produce recombinant proteins containing His-tag at the
N-terminus. Proteins were subsequently purified with Ni-nitrilo-
triaceticacid (NiNTA) resin (Qiagen).
Preparation of Cell lysates, Immunoblotting, and
Immunoprecipitation
Cell lysates were prepared using cold NP-40 lysis buffer (0.5%
NP-40, 50 mM HEPES [pH 7], 250 mM NaCl, 5 mM EDTA,
0.5 mM EGTA [pH 8]) plus a protease inhibitor cocktail
(Complete, Roche), 1 mM sodium orthovanadate, and 1 mM
dithiothreitol as previously reported [19,21]. Differential extrac-
tion of nuclear and cytoplasmic proteins was performed as
reported previously [19,20]. Immunoprecipitations were per-
formed using 600 mg of total cell lysate in HNTG buffer (20 mM
HEPES, 150 mM NaCl, 10% glycerol, 0.1% Triton X-100) or in
PBS-0,2% NP40 (for stathmin and RhoA immunoprecipitates)
plus the specific agarose-conjugated primary antibody (FLAG-
M2 Affinity gel) and incubating overnight at 4uC. When primary
antibodies were not agarose conjugated, protein A or protein G
Sepharose 4 Fast Flow (Amersham Biosciences) was added
during the last 2 hours of incubation. Immunoprecipitates were
washed six times in HNTG buffer, and then nine parts were
resuspended in 36 Laemmli sample buffer with 50 mM
dithiothreitol and one part was resuspended in kinase buffer.
Kinase assays were performed as previously described [19,22]
using 2 mg of histone H1 as the substrate (Upstate Biotechnology)
and [c-
32P]ATP (PerkinElmer Life Sciences) to reveal phosphor-
ylation levels. p27 kinase inhibitory activity was also tested with
an in vitro assay using recombinant cyclin-CDK complexes.
Different amounts of recombinant p27 mutants were incubated
with 40 ng of recombinant cyclin A2-CDK2 complex (Signal-
Chem) or with 300 ng of cyclin D1-CDK4 (SignalChem)
complex, on ice for 1,5 hour. Then samples were subjected to
kinase assay using, respectively, histone H1 or Rb protein as the
substrate. For immunoblotting, 40 mg of proteins was separated
by 4–20% SDS-PAGE (Criterion precast gel; Bio-Rad) and
transferred to nitrocellulose membranes (Hybond C; Amersham
Inc.). Membranes were incubated with primary antibodies as
indicated and then with horseradish peroxidase-conjugated
secondary antibodies (GE Healthcare) for ECL detection (GE
Healthcare) or Alexa-conjugated secondary antibodies (Invitro-
gen) for Odyssey infrared detection (Licor). For immunoprecip-
itates, rabbit immunoglobulin G and mouse immunoglobulin G
True Blot (eBioscience) secondary horseradish peroxidase-
conjugated antibodies were used. Quantification of the immu-
noblots was done using the QuantiONE software (BioRad) or the
Odyssey infrared imaging system (Licor Biosciences). Primary
antibodies were from: Transduction Laboratories (p27, meta-
blastin/stathmin and CDK2), Santa Cruz (p27 C19, p27 N20,
CDK4, vinculin, Skp2), Clontech (Zs green polyclonal antibody),
Sigma (Op18/stathmin), Upstate (RhoA), as marker of nuclear
extracts we used an anti-HMG2A kindly provided by Prof. G.
Manfioletti.
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In vitro transcription-translation was performed using the TNT
T7 Quick Coupled Reticulocyte Lysate System (Promega). p27
wt
and p27 mutants cDNAs were cloned in the pTNT vector
(Promega) and 1 mg of circular plasmid was added directly to TNT
Lysate and incubated in a 50 ml reaction for 1.5 hours at 30uC.
The reaction mix contained [
35S] methionine (PerkinElmer Life
Sciences) for the detection of translated proteins. Before doing the
experiment, 100 ng of each plasmid were loaded into an agarose
gel for mass standardization.
In vitro protein degradation assay
Invitrodegradation ofp27 wascarried outessentially aspreviously
described [5]. Briefly, HT1080 cells were transfected with pHA-
Ubiquitinvector and lysed48 hours laterinice-colddouble-distilled
water. The sample was frozen and thawed 3 times, and then spun
down to pellet debris. The supernatant was retrieved and frozen at
280uC. 1 mg of histidine-tagged p27 was incubated at 37uC for
different times in 50 ml of degradation mix containing 200 mgo f
lysate from HT1080 cells, 50 mM Tris-HCl (pH 8.0), 5 mM
MgCl2, 1 mM DTT and 2 mM ATP. After the indicated times,
reactions were stopped by adding 56Laemmli buffer and loaded
onto 4–20% polyacrylamide gel. p27 degradation was analyzed by
immunoblotting with an anti-p27 monoclonal antibody.
RNA Extraction, RT-PCR and Real-Time PCR
Total RNAfrom transfected cellswasextracted usingthe RNeasy
kit (Qiagen). Two micrograms of total RNA was retrotranscripted
using AMV Reverse Transcriptase and random hexamers accord-
ing to the provider’s instruction (Promega); 1/20 of the obtained
cDNAs were then amplified using the upstream primer for the
human p27 sequence and the M13 reverse primer that target
pDNR vector, to not amplify endogenous p27 transcript, or with
primers for human GAPDH mRNA. Quantitative Real-Time PCR
analysis was performed with the same cDNAs using SYBR Green
PCR Core Reagents (Applied Biosystems).
Analyses of cell proliferation
To evaluate cell cycle progression 3T3 p27
KO cells were
transduced with the indicated mutants and 24 hours after
transduction cells were starved and then released in DMEM
complete. DNA content was determined by propidium iodide
staining using FACS analysis as previously reported [19]. Data
were analyzed with a cell cycle analysis software program to
calculate the distribution of cells in G1, S and G2/M phases of the
cell cycle. For colony assay, 24 hours post-transduction SCC9 cells
were trypsinized, counted and seeded at density 1000 and 5000
cell/100 mm dish and incubated in their complete growth
medium. Two weeks later plates were stained with crystal violet
and colonies counted. Results were expressed as percentage of
growth inhibition comparing the colony numbers of each
condition to the colony numbers formed in the plate transduced
with AdGFP control vector. Experiments were performed in
quadruplicate and data represents the mean value of three
independent experiments. The transduction efficiency was calcu-
lated counting the number of green cells in 10 randomly selected
fields, 24 hours after transduction. After 15 days, 60–80 colonies
were counted for each mutants and the percentage of green
colonies was determined.
Morphology in 3D
For the evaluation of cellular morphology in 3D matrix,
U87MG cells were included in Matrigel (6 mg/ml; BD) 10-ml
drops on a coverslip (5000 cells/drop) and maintained for 1 hour
upside down at 37uC, to allow Matrigel polymerization. Then,
complete medium was added. Drops were incubated for 24 hours
and photographed using a phase-contrast microscope to evaluate
cell morphology.
Time-Lapse video microscopy
For the evaluation of cell motility following adhesion to FN cells
were transfected with EGFP-p27 plasmids in the presence or not
of DsRed-Stathmin vectors and 24 hours later plated on FN
coated glass bottom dishes (WillCo Wells BV) that allow the use of
the 636immersion glycerin objective. Cells were then incubated
at 37uCi n5 %C O 2 atmosphere in the Leica Time Lapse
AF6000LX workstation equipped with the Leica DMI 6000
motorized microscope and an environmental chamber for the
proper setting of temperature humidity and CO2 concentration.
The microscope allows the acquisition of multiple fields on the X,
Y and Z axes and is computer assisted. The AF6000 Software
(Leica) allows the acquisition of the images on the desiderate
frames and periods of time. Images were collected every 2 minutes
for 2 hours and used to create a video (15 images per second) and
analyzed with a cell tracking software (Leica) to collect different
locomotion parameters [21,24]. In brief, cells were randomly
selected and their x/y coordinates tracked using the IM2000
software (Leica), which allows automated or manual cell tracking
in order to obtain cell speed (micron/min) and total distance
covered (micron) by the cells. At least 3 independent wells/cell
type have been analyzed.
Migration experiments
Migration assays were performed essentially as previously
described [19]. Briefly, bottoms of HTS Fluoroblok (Becton
Dickinson) were coated overnight at 4uC with 10 mg/ml FN, and
then saturated 2 hours at room temperature with PBS 1% BSA.
Cells were seeded in the Fluoroblok
TM upper chamber and then
incubated at 37uC for the indicated times. Migrating cells were
evaluated by reading at different time points the lower and the
upper sides of the membrane with the Spectrafluor reader (Tecan).
Each experiment was performed at least 3 times, in duplicate.
Migration was then blocked by fixing the Fluoroblok membranes
in 4% PFA to allow the count of migrated cells.
Results
p27 protein expression is affected by the T198A point
mutation but is not dependent on the T198
phosphorylation
We recently demonstrated that the C-terminal portion of p27 is
important for its ability to control MT stability via stathmin
interaction and this, in turn, impinge on cell motility [19–21,24].
By studying the effects of p27
WT protein on the regulation of
glioblastoma cell growth and motility we observed that the WT
protein was able to stimulate the formation of neuron like
protrusions in U87MG cells (Video S1), thus confirming our
previous observation that p27 is able to control protrusion
formation in 3D context [24], also in glioblastomas. Further data
demonstrated that p27 stimulated protrusion formation in
U87MG cells through its C-terminal tail, since the deleted mutant
p27
1–170 was ineffective (Figure 1A). To better understand the
mechanism of regulation of cell shape and motility by p27, we
decided to generate specific point mutants in those residues
comprised among amino-acids 170 and 198 that have been
proposed to have a role in the regulation of p27 protein. Indeed,
two residues appeared of particular interest in this region, namely
p27kip1 Regulation by C-Terminal Modification
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degradation of p27 [11] and the T198 which has been proposed to
regulate protein stability [18], autophagy [25] and cell motility
[17].
First, we generated a p27
T198A non-phosphorylable mutant to
verify whether or not the modification of p27 last amino-acid had
any role in morphological and motility phenotypes of glioblastoma
cell lines. Adenoviruses expressing the WT, the 1–170 and the
T198A p27 proteins were generated and used to transduce the
U87MG cell line. The T198A mutation resulted in a strong
abrogation of p27 protein expression (Figure S1). This effect was
independent from the phosphorylation of the T187 since it was not
rescued by the concomitant mutation of T187 in Alanine and were
confirmed using DNA transfection instead of adenoviral trans-
duction using 3 different cell lines (Figure S1 and Figure 1B).
Altogether these data confirm that T198 is a key residue for p27
protein stability and its effect is not dependent on the
phosphorylation of T187.
In contrast with this observation several lines of evidence
demonstrated that the p27
1–170 mutant (that lacks both the T198
and the T187 residues) has an expression comparable to that of the
WT protein (Figures 1B, 2B, S1) and references [19,21]. In order to
clarify this point the p27
1–197 mutant was generated in which only
the last amino-acid was deleted. As shown in Figure 1, p27
1–197 was
expressed at levels similar to the WT protein indicating that the
phosphorylation of p27 on T198 is not required to govern the
protein stability (compare lane 1 with lane 11 in Fig. 1B).
We then reasoned that the Threonine homolog non-phosphor-
ylable amino-acid is the Valine and not the Alanine while the
Glutamic Acid (E) and Aspartic Acid (D) represent the pseudo-
phosphorylated mutation of Threonine and Serine, respectively
(Figure S2). In accord with the observation obtained with the
deletion p27
1–170 and p27
1–197 mutants, both T198V and T198E
mutants displayed an expression level similar to that of the WT
p27 protein (compare lane 1 with lanes 7 and 9 in Figure 1B).
Similarly, the double mutants T187A-T198E and T187A-T198V
were expressed as the WT protein (Figure 1B).
Being the Alanine the smallest of the 20 amino-acids after the
Glycine, we hypothesized that the steric hindrance of the last
amino-acid in p27 rather than the addition of a phosphate group
to the T198 was important for the correct expression of the
protein. To prove this hypothesis the p27 T198 was changed
either in Glutamic Acid (D), Serine (S), Phenylalanine (F) or
Glycine (G). All the mutants but T198G displayed level of
expression similar to that of the WT protein (Fig. 1B). Consis-
tently, the double mutant T187A-T198G was expressed at very
low level when compared to the expression of the WT protein
(Figure 1B). Thus, only the substitution of T198 with A or G, the
two smallest amino-acids, resulted in the reduced p27 expression,
confirming that the size of the last amino-acid rather than the
Threonine phosphorylation was important for the regulation of its
expression.
p27
T198A displays an increased proteasome-dependent
degradation that is not dependent on the T198
phosphorylation
We then tried to understand the mechanism by which the
T198A/G substitution could regulate p27 expression. We first
looked at the transcription of the different constructs that, as
expected, was similar in all mutants as indicated by semiquanti-
tative RT-PCR (Figure 1C). These results were confirmed by
quantitative Real Time PCR experiments coupled with western
blot analyses in the same transfectants. The results of three
independent experiments showed in Figure 1D obtained by
comparing the protein expression (in arbitrary units) with the
fentomoles of p27 mRNA present in each transfectant, demon-
strated that when the T198 in p27 was mutated in G or A only 1/
10 of the protein was found per each fentomole of mRNA as
compared with the ratio observed for the WT protein (Figure 1D).
In any of the other mutants tested we were not able to find any
significant difference with the ratio observed for the WT protein.
Using in vitro transcription-translation assays we also excluded
that the differences in protein expression resided in the ability of
the mRNA to be correctly translated in protein since similar
amount of protein was produced in vitro per each nanogram of
plasmid used (Figure 1E).
Collectively these data suggested that the different expression of
p27
T198A/G mutants could be linked to differences in protein
stability. To test this hypothesis we looked at the stability of p27
WT
and mutant proteins in cells treated with cycloheximide (10 mg/
ml) for different times. This experiment clearly showed that the
stability of mutants containing either G or A as last amino-acid
was lower than that observed for the WT protein, with an half life
of about 4,5 hours for the A/G containing mutant respect to about
12 hours for the WT or the non A/G T198 (T198E and T198V)
mutants (Figure 2A).
As a complementary approach we utilized recombinant p27
proteins produced in E. coli and analyzed them in a proteasome
dependent degradation assay. Western blot analysis demonstrated
that the degradation rate of p27
T198A/G mutants tested in the
presence of proteasomal extract derived from HT-1080 cells
transfected with HA-tagged ubiquitin was higher respect to that of
the WT protein or substituted with the V or E amino-acids
(Figure 2B). Quantitative analysis demonstrated that mutants
containing p27
T198A/G displayed a half-life of about 2.5 hours
respect to the 7–9 hours of p27
T198V, p27
WT or p27
T198E. Also in
this case the concomitant mutation of T187 was not able to rescue
p27 stability (Figure 2B), demonstrating that the presence of A/G
in the last position of p27 was dominant respect to the mutation of
T187. Accordingly, the p27
1–170 mutant that lacks both T198 and
T187 resulted even more stable in the same assay (Figure 2B).
These data suggested us that the presence of a small amino-acid
in the last residue of p27 protein resulted in increased proteasome
dependent degradation and that this process was independent
from the phosphorylation of T187. Since phosphorylation of T187
is an event necessary for the Skp2 mediated degradation of p27
[7–9,11], our data pointed to a Skp2 independent pathway leading
to p27 down-modulation.
This hypothesis was sustained by subsequent results coming
from experiments using MDAH 2774 cells where the Skp2
silencing level was optimal. Use of shRNA directed against Skp2
resulted in increased expression of the p27
WT, p27
T198V or
p27
T198E proteins but produced only minor effects on the half-life
of p27
T198A or p27
T198G (Figure 2C). However, the experiments
confirmed that the low levels of p27
T198A/G were due to their
enhanced protein degradation since their expression could be
rescued by the treatment of the cells with the proteasome inhibitor
MG132 (Figure 2D).
Mutation of T198 in Alanine increased proteasome
dependent degradation of p27 independently by its CDK
binding ability
We also tested the possibility that CDK2 binding could be
involved in the regulation of p27
T198A/G stability. To this aim we
generated p27
CK2 mutants in which the 30–32 and 62–64 amino-
acids were mutated and the p27 binding ability to the CDK2/
cyclin A/E complexes abolished [26]. The expression levels of
p27
CK2 were similar to those of the WT protein (data not shown).
p27kip1 Regulation by C-Terminal Modification
PLoS ONE | www.plosone.org 4 March 2011 | Volume 6 | Issue 3 | e17673Figure 1. p27 protein expression is affected by the T198A/G point mutation. A. U87MG cells were transduced with the indicated Ads,
included in 3D Matrigel matrix and images were taken 24 hours later (206objective). In the graph the length of cell protrusions is reported. Data
represents the mean value (6 standard deviation) obtained measuring protrusions length in at least 20 cells for each type of transduction in 3
independent experiments. B. Western blot analysis of p27 expression in SCC9 cells transiently transfected with different p27 mutants cloned in the
pDNR vector and analyzed 48 hours after transfection. Vinculin was used as the loading control. (A=alanine, G=glycine, S=serine, V=valine,
D=aspartic acid, E=glutamic acid, F=phenylalanine). C. RT-PCR on RNA extracted from SCC9 treated as in B. GAPDH was used as internal control.
NT=Non Transfected cells, C RNA=amplification of non retro-transcribed RNA. D. SCC9 cells were transfected with pDNR p27
WT and with the
indicated mutants and 48 hours later RNA and protein extracts were prepared from each plate. Results represent the ratio between the fentomoles of
p27-mRNA evaluated by qRT-PCR analysis and the amount of p27 protein expression evaluated by densitometric analysis of the blots and normalized
to the loading control vinculin. Data represents the mean value (6 standard deviation) of three independent experiments. Statistical analysis was
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CK2 was also mutated in the last amino-acid in either A,
G or V, only the p27
CK2/T198V mutant was expressed at levels
similar to that of the control protein (Figure 3A). Immunoprecip-
itation experiments demonstrated that as expected the CK2 p27
mutants did not bind the CDK2 protein (Figure 3B) and the
analysis of protein stability in the presence of cycloheximide
demonstrated that the CK2 mutation did not alter the stability of
p27
T198A/G mutants in two different cell lines (Figure 3C and
Figure S3).
It has also been proposed that the phosphorylation of Tyrosines
74, 88 and 89 is important for p27 protein degradation and is
related to conformational changes in its C-terminal tail. We thus
hypothesized that they could be involved in the generation of the
phenotype observed with the T198A/G mutants. Preventing the
phosphorylation of either Y74 or Y88 did not alter the stability of
the T198A mutant although the single substitution in Y74 or in
Y88 slightly increased p27 protein stability, as judged by
experiments of cycloheximide treatment (Figure 3D). In this
setting, the half life of p27
Y74F-T198A and p27
Y88F-T198A was about
5 hours, thus similar to the p27
T198A mutant, while that of the
single p27
Y74F and p27
Y88F was about 15 hours, thus longer than
that of the WT protein (12 hours of half-life).
Altogether these data demonstrate that the T198A/G substitu-
tion causes an increased degradation of p27 protein but that this
effect is not related to the binding with the Cyclin/CDK
complexes.
The lack of p27 phosphorylation on T198 does not affect
cancer cell proliferation
The phosphorylation of p27 on T198 has been linked to the
control of cell growth and motility [17–18]. To verify whether or
not this was true also in our model system we compared the effects
of the overexpression of the p27
T198A mutant with that of p27
WT,
p27
T198E and p27
T198V proteins on the regulation of both cell
proliferation and motility.
To evaluate cell growth we transduced SCC9 squamous cell
carcinoma with an adenovirus encoding the GFP protein together
with the different p27 mutants, under the control of two different
CMV promoters. Using this tool it is possible to follow the
transduced cells that express the exogenous protein avoiding the
influence of the GFP protein on the studied transgene. Moreover,
the expression of the GFP protein is not influenced by the protein
stability of the transgene, as occurs with the GFP-fusion proteins.
Accordingly, we observed similar levels of GFP protein in the
transduced cells coupled with high expression of p27
WT, p27
1–170,
p27
T198E and p27
T198V proteins while, as expected, with low
expression of the T198A mutants (Figure 4A). The colony assay
experiment demonstrated that overexpression of p27
WT, p27
1–170,
p27
T198E and p27
T198V proteins resulted in about the 60% of
growth inhibition (Figure 4B and C) when compared with controls
(non-transduced and GFP-transduced cells). This growth inhibi-
tion was directly related to the percentage of transduced cells, (69–
76% of GFP-positive cells by using the different Adenoviruses)
(Figure 4C). The inhibition exerted by the T198A mutants was less
than 20%, thus lacking any significant effect on cancer cell growth
(Figure 4B and C). The absence of cell growth inhibition by
p27
T198A (and p27
T187-198A) was likely due to the low levels of
proteins expression, as demonstrated by the count of green
colonies in cells transduced with the different Adenoviruses and
allowed to grow for 15 days. This experiment showed that while
less than 20% of cells expressing the WT protein or the p27
1–170,
p27
T198E and p27
T198V were green, more than 50% of the
colonies in cells expressing the p27
T198A protein were GFP-
positive (Figure 4D), thus demonstrating that the overexpression of
p27 in SCC9 cells was able to inhibit cell growth independently
from phosphorylation of T198, but only when expressed over a
threshold level.
To further analyze the effects of these mutants overexpression in
cell cycle, and being p27 mainly involved in G1/S transition, we
studied more in details how T198 substitution affects this event.
For this purpose 3T3 p27
KO were transduced with p27
WT,
p27
T198E and p27
T198V serum starved for 24 hours and released in
complete medium. Cell cycle reentry was evaluated by FACS
analysis and biochemically looking at the expression of cyclin A,
used as marker of S phase entry. Data showed that no significant
differences could be observed in the ability to enter into the cell
cycle among the different mutants analyzed. In fact at 16 hours
the percentage of S phase cells was 18%, 17%, and 16% for
p27
WT, p27
T198E and p27
T198V, respectively (Figure S4) coupled
with a similar increase in the levels of the S phase marker Cyclin
A. Moreover, the levels of p27 expression at the same time points
were not affected by the mutation of the T198, confirming the
results obtained in exponentially growing cells (Figures 1 and 2).
It has been proposed that the T198A mutation results in a
higher inhibition of CDK2 containing complexes [18]. We thus
tested whether or not T198A substitution could change the ability
of p27 to bind CDK2- or CDK4-containing complexes and
whether this effect could be related to the lack of T198
phosphorylation.
To this aim 3T3 p27
KO cells have been transduced with vectors
encoding for p27
WT, p27
T198A, p27
T187-198A or p27
T198V and the
exogenous proteins immunoprecipitated (Figure 5A). The amount
of CDK2 and CDK4 bound to the different mutants was then
evaluated and normalized respect to the amount of the
immunoprecipitated protein (Figure 5B). Results show that
T198A protein displays a 3 fold higher affinity for CDK2 respect
to the WT one (p,0.01), while the affinity for CDK4 was similar
for all mutants (p.0.05) (Figure 5B), thus confirming the results
obtained from others [18]. However, an in vitro assay performed
using either CyclinA2/CDK2 or Cyclin D1/CDK4 recombinant
complexes, demonstrated that the ability of p27
WT, p27
T198A,
p27
T198G, p27
T198D or p27
T198V recombinant proteins to inhibit
the CDKs kinase activity was comparable in all mutants
(Figure 5C). These data demonstrated that although the T198A
mutation increased the ability of p27 to bind the CDK2
containing complexes it did not alter its ability to inhibit the
kinase activity and that the effects observed with the T198A
mutation cannot be related to the lack of T198 phosphorylation
since the T198V and T198D mutants displayed an activity similar
to that of the WT protein.
The T198 phosphorylation in p27 regulates cells motility
In the last years, a role in the regulation of cell motility has been
proposed for p27. In particular, some studies reported a role for
T198 phosphorylation in cell motility [17]. To avoid any possible
misinterpretation due to the increased proteasomal degradation of
p27
T198A, we compared the activity of p27
T198E and p27
T198V that
have a similar expression and a similar half-life in our cell lines
carried out using Student’s t test. E. p27
wt and the indicated T198 mutants cDNAs were in vitro transcribed and translated, loaded into SDS-PAGE gel
and subjected to autoradiography. Inset shows control of plasmidic DNA quantification used in this experiment. Luc=luciferase positive control
vector, E.V.=empty vector.
doi:10.1371/journal.pone.0017673.g001
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PLoS ONE | www.plosone.org 6 March 2011 | Volume 6 | Issue 3 | e17673Figure 2. T198A/G substitution markedly decrease p27 protein stability. A. Western Blot analysis of p27 expression in SCC9 cells were
transfected with the indicated p27 mutants and 48 hours later treated with cycloheximide (CHX) for 3, 6 and 9 hours. The densitometric analysis of
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WT, p27
T198E
or p27
T198V proteins had any effect on the ECM-driven motility
using different experimental settings. We already demonstrated
that p27 is able to inhibit the motility of several human cancer cell
lines, including HT-1080 fibrosarcoma cells (Figure 6) and [19]
and U87MG [data not shown and Ref 20] in transwell migration
assays. As already reported, the p27
1–170 deletion mutant did not
affect the ability of these cells to respond to haptotactic stimuli
(Figure 6) and [19–21]. The use of p27
1–170, p27
T198E or p27
T198V
revealed that the phosphorylation of T198 plays a role in the
regulation ECM-driven motility. As shown in Figure 6A both
p27
1–170 and p27
T198V were unable to properly inhibit HT-1080
and U87MG cell migration through a FN-coated transwell while
the pseudo-phosphorylated mutant p27
T198E displayed an activity
the blots is reported in the graph (right) and is expressed as percentage of remaining protein respect to untreated cells. B. Western Blot analysis of
p27 recombinant proteins in in vitro degradation assay using bacterial His-tagged recombinant p27 proteins incubated with proteasome extracts for
3, 6 and 9 hours. Quantification of this degradation assay is reported in the right graph and expressed as described in A. C. Western blot analysis of
p27 and Skp2 expression in MDAH cells transduced with AdSkp2 or with AdNeg (Control) shRNAs in which the different p27 proteins were expressed
and treated or not with CHX for 6 and 9 hours. Total protein extracts were analyzed by western blot using the indicated antibodies (left). The
densitometric analysis of a representative Skp2 silencing experiment is reported in the graph (right) and expressed as in A. D. Western blot of 3T3
p27
KO fibroblasts expressing the different p27 mutants as indicated and treated with MG132 (50 mM) or DMSO for 6 and 9 hours. A typical
experiment is shown.
doi:10.1371/journal.pone.0017673.g002
Figure 3. p27
T198A/G increased proteasome-dependent degradation is not dependent on CDK-binding. A. Western blot analysis of p27
expression in HT1080 transfected with the indicated vectors and analyzed 48 hours after transfection. B. Western blot analysis of p27 and CDK2
expression in SCC9 cells transfected with the indicated FLAG-p27 or control (pFLAG-BAP) vectors analyzed 48 hours after trasfection. The amount of
CDK2 bound to the different p27 mutants is shown in the right blots (IP anti-FLAG). C and D. Western blot analysis of p27 expression in HT1080
transfected with the indicated vectors treated with CHX for 3, 6 and 9 hours. In the graph is reported the densitometric analysis of the blots.
doi:10.1371/journal.pone.0017673.g003
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confirm these results we used video time-lapse microscopy to track
the motility of p27-EGFP-fusion proteins expressing cells. In these
conditions we have been able to look also at the subcellular
localization of the transgene, during the migration. Thus, cells
were transfected with EGFP-p27
T198E or -p27
T198V and 1 day
later plated on FN-coated dishes and followed for 2 hours using a
fluorescence-based time lapse analysis. Strikingly, video time lapse
coupled with cell tracking analyses demonstrated that the
expression of EGFP-p27
T198V both into the nucleus and into the
cytoplasm did not interfere with the ability of U87MG cells to
properly move on FN (Video S2 and Figure 6C). On the contrary,
the expression of the T198E mutant in the cytoplasm (Video S3
and Figure 6C) but not in the nucleus (Video S4 and Figure 6C)
almost completely blocked cell motility.
We also verified whether T198 phosphorylation may affect cell
motility by favoring p27 nucleo-cytoplasm shuttling [17]. Howev-
er, in our model system both time-lapse video-microscopy and
western blot analyses did not confirm a primary role of T198
phosphorylation in the regulation of p27 subcellular localization
following cell adhesion (Figure S5).
The ability of p27 to modulate cell migration has been
previously ascribed by its ability to bind other proteins more
directly implicated in the regulation of cellular motility, namely
RhoA and stathmin [17,19–21]. First we focused on the possible
binding of p27 with the small GTPase RhoA, that has been
already reported to be influenced by the T198 phosphorylation
[17]. To this purpose, we overexpressed in HT-1080 cells both
GFP-RhoA and flag-tagged p27
WT,p 2 7
1–170,p 2 7
T198E or
p27
T198V proteins and adhered them to FN for 1 hour. No
Figure 4. The lack of p27 phosphorylation on T198 does not affect cell cycle progression. A Western blot analysis of p27 and Zs green
expression in SCC9 cells transduced with the indicated AdZsgreen viruses and analyzed 24 hours post-transduction. B. Typical image of colony assay
analysis in SCC9 cells transduced as in A and allow to grow for 15 days. C. Quantification of growth inhibition induced by the different p27 proteins
respect to control cells evaluated by colony assay. Data represents the mean value of three independent experiments performed in quadruplicate.
The mean transduction efficiency (% of green cells over the total) is reported. D. Percentage of colonies expressing the Zs Green protein 15 days post-
transduction as determined counting at least 80 colonies for each mutants. A representative experiment is shown.
doi:10.1371/journal.pone.0017673.g004
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appreciable in our system (Figure S6A). Similarly, in cells
adhered to FN for 1 hour we did not observe the binding of
endogenous p27 and RhoA proteins (data not shown). It has been
demonstrated that p27 C-terminal tail binds also the MT-
destabilizing protein stathmin [19–20]. We thus speculated that
T198 phosphorylation may favor this interaction in cells adhered
to FN. Cells expressing p27
T198E or p27
T198V proteins, or the
p27
1–170 deletion mutant both as untagged or EGFP-tagged
proteins, were co-transfected with FLAG- or DS-Red-tagged
stathmin vectors and then adhered to FN for 1 hour. Protein
extracts have then been immunoprecipitated using either the
anti-p27 (Figure S6B) or the anti-stathmin (Figure 6B) antibodies.
Data unveiled that while the association between p27
T198E and
stathmin was readily detectable (Figure 6B and Figure S6B) the
T198V mutation strongly impaired this association (Figure 6B
and Figure S6B). As expected and already reported [19–20], the
deletion of the last 28 amino-acids prevented it (Figure S6B).
Importantly, stathmin/p27 interaction was observed only in the
cytosolic (Figure 6B) and not in the nuclear fraction (data not
shown). To further prove that the interaction between p27 and
stathmin plays a role in the control of adhesion dependent cell
Figure 5. p27
T198A and p27
T187-198A bind CDK2 with high affinity. A. Immunoprecipitation analysis of 3T3 p27
KO fibroblasts transduced with
the indicated Ad Zs-green p27 and lysed 48 hours post-transduction. IP and lysates were analyzed by western blot using anti-CDK2, anti-CDK4 and
anti-p27 antibody. B. Quantification of p27/CDK2-4 interaction as evaluated by IP and western blot analysis. Data represents the mean value (6
standard deviation) of three independent experiments and are expressed as fold increase respect to the p27
WT/CDK binding value. C. In vitro kinase
assay of recombinant cyclin A2/CDK2 complex in the presence of increasing amounts (0,5, 1 and 2 mg) of recombinant His-tagged p27
WT and mutants
proteins as indicated using histone H1 as substrate. In the upper panel the expression of p27 in each reaction is shown. In the lower panel the
phosphorylated Histone H1 is shown. A typical assay is reported. In the lower graph the amount of p27 proteins present in each reaction as evaluated
by densitometric scanning of the blots is shown. In the lower table the percentage of kinase activity inhibition by the different p27 mutants respect
to control kinase activity is reported. D. Same as in C using as kinase the recombinant cyclin D1/CDK4 complex and pRB fragment as substrate.
doi:10.1371/journal.pone.0017673.g005
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T198 phosphorylation we co-expressed in U87MG cells the
DsRed-stathmin and the EGFP-p27
T198E protein. Cells were
then allowed to adhere to FN coated plates and followed by
video-time lapse microscopy. As shown in Figure 6C stathmin
expression completely abrogated the ability of cytoplasmic
p27
T198E to inhibit cell motility (Figure 6C and Video S5).
Moreover, the two proteins co-localize in the cytoplasm in
response to cell-FN interaction as evaluated by time-lapse
confocal video-microscopy (Video S6).
Altogether these data demonstrated that T198 phosphorylation
is an important event that may favor the p27/stathmin interaction
eventually influencing ECM-driven cell motility.
Discussion
Here, we investigate the role of T198 phosphorylation in cell
growth and motility demonstrating that this event is important in
the regulation of cell motility while it does not affect cell
proliferation. This observation is in accord with previous studies
demonstrating that the C-terminus of p27 is involved in the
control of migration but not of cell cycle progression [19–21]. We
also demonstrate that p27 T198 phosphorylation favors the
interaction between p27 and stathmin following cell adhesion to
ECM, thus suggesting the mechanism by which the T198
modification could affect cell motility. These data are in
agreement with our [23] and others’ [27,28] observations, showing
Figure 6. p27 T198 phosphorylation participate in the regulation of cell motility by p27. A. HT1080 cells were transduced with the
indicated Ad Zs-green p27s and 24 hours later allowed to migrate on FN-coated Fluoroblok. A typical image of Fluoroblok bottom (Migrated cells) is
shown. In the graph the quantification of migrated cells is reported. Results are expressed as fold induction respect to control cells. B. IP analysis on
cytoplasmic fractions of HT1080 expressing pEGFP-p27 mutants and DsRed-stathmin as indicated and adhered on FN for one hour. Cytosolic lysates
and IP proteins were then evaluated by western blot analysis using anti-p27 and anti-Stathmin antibodies. C. Orthotopical projection of cell paths of
U87MG cells transfected with DsRed-Stathmin, EGFP-p27
T198V and EGFP-p27
T198E allowed to adhere on FN and followed for two hours (left). In the
figures yellow dashed lines delimitate the cytoplasm and blue lines the nucleus positions at time 0. In the graph (right) the speed of the transfected
cells is reported and represents the mean (6SD) of three independent experiments in which at least 10 cells/experiment were tracked. Statistical
analysis was carried out using Mann-Whitney U-Test.
doi:10.1371/journal.pone.0017673.g006
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migration and metastasis formation. The role of stathmin in cell
motility is particularly evident in in vivo and in three dimensional
settings [23,27,28], which probably represent the experimental
situation in which cell plasticity is of particular importance.
We also provide evidence that in this experimental setting the
p27/RhoA interaction is not implicated since no direct binding
between the two proteins was detectable, even after overexpression
of both proteins (Figure S6A). However, we recently demonstrated
that the interaction between p27 and stathmin indirectly affects
RhoA activity in mouse fibroblasts. In the absence of p27,
increased MT-dynamics results in increased RhoA activity,
following cell adhesion to ECM [24]. We cannot exclude that
this mechanism works also in this system and that RhoA activity
participates to the motile phenotype observed in the cells
expressing the different p27 mutants. It is to note that the
inhibition of the Rho-Rock1 activity results in the formation of cell
protrusion in several model system [24,29–31], and we demon-
strate here how overexpression of p27 induced protrusion
formation in U87MG included in 3D matrices and/or adhered
to ECM substrates (Figure 1A and Video S1). This event is
dependent on the presence of the last 28 amino-acids and partially
on the phosphorylation of T198. In fact we noticed some
differences between the activity of p27
1–170 deletion mutant and
the p27
T198V point mutant in the regulation of cell motility and
protrusion formation and also in stathmin binding capacity. These
observations suggest that other residues are important in the
regulation of cell motility within the C-terminal portion of p27 and
future work will better define the modifications required for proper
regulation of cell motility. The relevance of the p27-stathmin-MT
dynamics-Rho axis we recently highlighted [24] in the generation
of cell protrusion is confirmed by several experimental evidences
that demonstrate how p27 [32–33] and stathmin [34–35]
participate in the neurite protrusion formation and in the
regulation of neuronal migration, at least in part by modulating
Rho small GTPase activity [33,34]. Our study also suggest that
phosphorylation of the last aminoacid did not influence p27
protein subcellular localization. This observation was obtained
either by differential extraction of nuclear and cytosolic proteins
(Figure S5) and by video time lapse microscopy demonstrating that
the frequency of nucleo-cytoplasmic shuttling following cell
adhesion to ECM was similar for cells expressing p27
T198V or
p27
T198E (data not show).
On the other hand, our results suggest that phosphorylation of
T198 has no effect on cell proliferation and p27 protein stability.
These conclusions were drawn by the use of several point mutants
and by a number of different approaches that demonstrated how the
pT198 does not participate neither in the regulation of p27
proteasomal degradation, nor in its ability to bind the Cyclin-CDK
complexes and not even in the regulation of cancer cell growth. These
data are only apparently in contrast with some previous publication
[18]. We in fact confirmed that the T198A substitution results in
increased protein degradation, yet this is not dependent on the T187
phosphorylation and it is not dependent on the binding with the Skp2
protein, as previously suggested [18]. Our data support the possibility
that the effects observed with the p27
T198A mutant do not reflect a
lack of phosphorylation but the presence of a small residue in the last
position of p27 protein that may alter the natural unstable and
unstructured conformation of p27 C-terminal tail [14,36]. This
conclusion is sustained by several observations and by the use of
several mutants differing one each other only for the residue chosen
for the substitution of T198 (Figures 1, 2, 3), and it was independently
reached by others who recently demonstrated how a protein with a
premature stop codon at amino-acid 177 (that results in the presence
as last aminoacid of D176) did not display any defect in protein
stability when compared to the WT protein [37]. Accordingly, by
increasing the size of the last amino-acid from Glycine to
Phenylalanine, that contains a big aromatic ring in its structure, the
stability of the proteins increased. Moreover, the less stable protein
resulted the T-G substitution followed by the T-A and T-V point
mutations, which clearly indicated that the steric hindrance of the last
amino-acid is a key issue. Vice versa the T198E/D substitutions that
mimic the phosphorylation event, did not confer any increased
stability to p27 protein both invitroand in vivo.T h u si ti sn o tt h ela c ko f
T198 or the lack of its phosphorylation that is responsible for higher
protein degradation but only the conformation assumed by p27 when
a small amino-acid, such as Alanine or Glycine is present at the very
end of the unstructured tail. We can hypothesize that the T198A/G
substitution results in an unstable conformation of the C-terminal tail
of p27, which is then more rapidly recognized and degraded via the
unfolded protein degradation system. Accordingly, it has been
demonstrated that, under particular stress conditions, p27 is
recognized by the heat-shock protein Hsp27 and this interaction
eventually results in accelerated protein degradation [38]. It is
interesting to note that in some cancer cell lines p27 C-terminus is
cleavedbyproteaseactivity[20,39–41]andthatthiseventcontributes
to control p27 expression levels. Thus, it is possible that such
cleavages may result in the exposition of a small aminoacid and then
in a more rapid degradation of p27 protein. Mass spectrometry
analyses of p27 protein in human tumors could provide a more direct
evidence of this hypothesis.
Our work provides new unexpected results on the role of T198
in modulating the functions of p27, and also raises concerns on the
correct interpretation of the results coming from studies focused on
phosphorylation of threonine and/or Serine only by the use of T/
A or S/A substitution.
In conclusion, we show here that the complex regulation of p27
functions include not only the phosphorylation of Threonine 198
but also the three dimensional conformation of its unstable C-
terminal tail and how these events eventually play a role in the
control of ECM-driven cell motility.
Supporting Information
Figure S1 A. Western blot analysis of p27 expression in U87MG
cells co-transduced with AdTRE p27/AdTet-ON 72 hours post-
transduction. Vinculin was used for loading control. B. Western
blot analysis of p27 expression in HT1080 cells transiently
transfected with different pEGFP-p27 mutants. C, Time course
analysis of p27 expression in SCC9 cells co-transduced with
AdTRE p27s/AdTet-ON (MOI 80:40 and 160:80) as indicated.
The expression of p27 and vinculin (loading control) evaluated by
western blot analysis is reported.
(TIF)
Figure S2 Comparison of Amino-acids lateral chains. As shown
by the structural formula, Valine and Glutamic Acid are,
respectively, the non-phosphorylable and phosphomimetic homo-
log of Threonine, while Alanine and Aspartic Acid are those of
Serine.
(TIF)
Figure S3 Western blot analysis of p27 expression in HEK 293
cells transfected with the indicated CK- mutants vectors and
treated with CHX for 3, 6 and 9 hours. The densitometric analysis
of the blots is reported in the graph (right) and is expressed as
percentage of remaining protein respect to untreated cells.
(TIF)
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KO fibroblasts were transduced with the
indicated Ad Zsgreen p27. 24 hours later cells were serum starved
in DMEM 0,1% BSA for 24 hours and then released in complete
medium. At the indicated time points cells were fixed and
analyzed by flow cytometry for their DNA content and total cell
protein extracts were prepared. Cyclin A and p27 levels are
reported in the upper panels as evaluated by western blot analyses.
Vinculin was used as loading control. The percentage of cells in
G1, S and G2/M phases of the cell cycle at each time point is
reported in the lower tables. Data represents the mean of three
independent experiments.
(TIF)
Figure S5 A. Western blot analysis of p27 expression in nuclear/
cytoplasmic extracts of HT1080 cells transfected with the
indicated FLAG-p27 mutants and adhered 48 hours later on
fibronectin for 1 hour. Vinculin was used as control for
cytoplasmic fractions and HMG2A as controls for nuclear
fractions. B. Evaluation of EGFP-p27 localization in U87MG
cells transfected with the indicated pEGFP-p27 vectors and
adhered to FN for two hours. Data are expressed as percentage
of cells with nuclear or cytoplasmic localization.
(TIF)
Figure S6 A. Immunoprecipitation (IP) analysis of HT1080
expressing FLAG-p27 and EGFP-RhoA proteins as indicated and
adhered on FN for one hour. Total cell lysates and IP proteins
were then evaluated by western blot analysis using anti-p27 and
anti-Rho antibodies. IPs were performed using both an anti-GFP
antibody and the FLAG-M2 affinity gel antibody. No co-
precipitation was observed in both the conditions. B. IP analysis
of HT1080 expressing p27 and FLAG-stathmin proteins as
indicated and adhered on FN for one hour. Total cell lysates
and IP proteins were then evaluated by western blot analysis using
anti-p27 and anti-Stathmin antibodies.
(TIF)
Video S1 Video time-lapse of U87MG cells transfected with
EGFP p27
WT and adhered on FN for 2 hours. p27
WT was able to
stimulate the formation of neuron-like protrusions and localizes in
the protrusions.
(MOV)
Video S2 Video time-lapse of U87MG cells transfected with
EGFP p27
T198V and adhered on FN for 2 hours. Expression of
p27
T198V both in the nucleus and in the cytoplasm did not
interfere with the ability of U87MG cells to properly move on FN.
(MOV)
Video S3 Video time-lapse of U87MG cells transfected with
EGFP p27
T198E and adhered on FN for 2 hours. Expression of the
T198E mutant into the cytoplasm almost completely blocked cell
motility.
(MOV)
Video S4 Video time-lapse of U87MG cells transfected with
EGFP p27
T198E and adhered on FN for 2 hours. Expression of the
T198E mutant into the nucleus did not interfere with U87MG
motility.
(MOV)
Video S5 Video time-lapse of U87MG cells cotransfected with
EGFP p27
T198E and with DsRed Stathmin and adhered on FN for
2 hours. Stathmin expression completely abrogated the ability of
cytoplasmic p27
T198E to inhibit cell motility.
(MOV)
Video S6 Time lapse confocal video microscopy of U87MG co-
transfected with EGFP p27
T198E and with DsRed Stathmin in
adhesion on FN for 2 hs. Yellow dots represented the colocaliza-
tion of p27
T198E (green) and stathmin (red) in response to cell-FN
interaction. Cells expressing only stathmin (red) or p27 (green) are
also present in the field. A single confocal plane was taken during
the experim.
(MOV)
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